umifenovir has been researched along with Cardiovascular Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Cao, Y; Fu, M; Guo, X; Hong, L; Yi, G; Ying, P; Zhang, Y | 1 |
1 other study(ies) available for umifenovir and Cardiovascular Diseases
| Article | Year |
|---|---|
Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review).
Topics: Angiotensin-Converting Enzyme 2; Antiviral Agents; Cardiovascular Diseases; Chloroquine; COVID-19; Host-Pathogen Interactions; Humans; Indoles; Molecular Targeted Therapy; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization | 2021 |